3B Blackbio Dx Limited (BOM:532067)

3B Blackbio Dx Revenue

3B Blackbio Dx had revenue of 396.34M INR in the quarter ending June 30, 2026, with 78.25% growth. This brings the company's revenue in the last twelve months to 1.55B, up 56.14% year-over-year. In the fiscal year ending March 31, 2026, 3B Blackbio Dx had annual revenue of 1.42B with 47.11% growth.

• Revenue (ttm): 1.55B
• Revenue Growth: +56.14%
• P/S Ratio: 6.49
• Revenue / Employee: 18.24M
• Employees: 85
• Market Cap: 10.06B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.42B	454.50M	47.11%
Mar 31, 2025	964.69M	220.55M	29.64%
Mar 31, 2024	744.13M	123.45M	19.89%
Mar 31, 2023	620.68M	-254.81M	-29.11%
Mar 31, 2022	875.50M	-1.42B	-61.87%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error